Alejandro Miguel Martín Dunn

Title: Alejandro Miguel Martín Dunn: Innovator in Antiviral Peptide Research

Introduction

Alejandro Miguel Martín Dunn is a notable inventor based in Playa La Habana, Cuba. He has made significant contributions to the field of biotechnology, particularly in the development of antiviral peptides. His work focuses on innovative solutions to combat viral infections, specifically targeting the Dengue virus.

Latest Patents

Alejandro holds a patent for "Beta hairpin peptides having antiviral properties against Dengue virus." This invention discloses structurally constrained synthetic peptides optimized for the formation of a beta hairpin structure. These peptides are capable of inhibiting or attenuating Dengue virus (DENV) infections. The patent also includes pharmaceutical compositions containing these synthetic peptides, which are useful for the prevention and/or treatment of DENV-caused infections. Additionally, the invention outlines a method for treating infections caused by this virus.

Career Highlights

Alejandro is affiliated with the Centro de Ingeniería Genética y Biotecnología, where he applies his expertise in peptide research. His work has the potential to significantly impact public health by providing new therapeutic options for Dengue virus infections.

Collaborations

Some of Alejandro's coworkers include Glay Chinea Santiago and Vivian Huerta Galindo. Their collaborative efforts contribute to the advancement of research in the field of biotechnology.

Conclusion

Alejandro Miguel Martín Dunn is a pioneering inventor whose work in antiviral peptide research holds promise for improving treatment options for Dengue virus infections. His contributions to biotechnology are noteworthy and reflect his commitment to advancing health solutions.